clinical_trials
Lower Metastasis Risk in Very High-Risk Prostate Cancer With Intensified Treatment
Confidence86·multiple reportsImportance88NP-EVT-20261026-4E5C81D
(MedPage Today) -- Men with very high-risk prostate cancer had a significantly lower risk of metastasis when they received darolutamide (Nubeqa) in addition to androgen deprivation therapy (ADT) and radiation therapy (RT), a randomized trial showed...
Read the original at the primary source
Lower Metastasis Risk in Very High-Risk Prostate Cancer With Intensified Treatment
10/26/2026, 3:34:29 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —